Ozi gbasara JYMed na 2023 API CHINA
【n'ebe ahụ】
N'okpuru nduzi nke osote onye isi njikwa Zhi Qin, Shenzhen JYMed Technology Co., Ltd.(nke a na-akpọkarị JYMed) sonyere na ihe ngosi a dị ebube.JYMed gosipụtara ngwaahịa bara uru Semaglutide, Liraglutide, Tirzepatide, Oxytocin, Copper Peptide na Acetylhexapeptide-8 wdg nye ndị ahịa na-eleta ụlọ ntu ahụ.Ndị ọrụ ahịa na-akọwara ndị ahịa site n'ọtụtụ akụkụ dị ka ngwaahịa na usoro mmepụta ihe.Mgbe inwetara miri emi nke JYMed na peptide akụrụngwa, ọtụtụ ndị ahịa ekwupụtala ebumnuche ha imekọ ihe ọnụ, na-atụ anya n'ihu mgbanwe na-achọ ịrụkọ ọrụ ọnụ iji mepụta ọhụrụ mmeri-emeri ọnọdụ maka imekọ ihe ọnụ.
【Onye ndu na teknụzụ peptide na nrụpụta ọrụ】
Shenzhen JYMed Technology Co., Ltd.tọrọ ntọala na 2009, raara onwe ya nye na nyocha na mmepe, mmepụta na ire nke peptides na peptide metụtara ngwaahịa.JYMed nwere otu R&D center na atọ isi mmepụta bases (20 peptide API mmepụta ahịrị na 4 formulation mmepụta ahịrị).Nkà na ụzụ nkwalite nzọụkwụ-site-nzọụkwụ ya nwere ike gboo mkpa nke ihe dị iche iche chọrọ, site na ọkwa mg ruo 50kg / batch, ma guzobe ahịrị peptide cytotoxic raara onwe ya nye (OEB4/OEB5) na ahịrị ọgwụ mgbochi peptide raara onwe ya nye.Ọ bụ otu n'ime ụlọ ọrụ nwere oke mmepụta nke ngwa ngwa peptide kemịkalụ na China.
Ndị otu R&D bụ isi nke JYMed nwere ihe karịrị afọ 20 nke ahụmịhe peptide wee gafere nyocha FDA ugboro abụọ.JYMed nwere sistemu nrụpụta peptide zuru oke ma rụọ ọrụ nke ọma, na-enye ndị ahịa ọrụ nrụpụta peptide zuru oke, gụnyere R&D, mmepụta, ndebanye aha, na nkwado iwu dị mkpa nke peptide APIs, peptide veterinary, peptide antibacterial, na peptide ịchọ mma.
Site n'inye akụrụngwa dị elu na nkwado teknụzụ ọkachamara, anyị na-agba mbọ ịmepụta uru maka ngwaahịa gị n'oge ọ bụla ma nyere gị aka ịgbasa ohere azụmaahịa ọhụrụ n'ahịa.
Ka anyị zute onwe anyị ọzọ na Ọktoba 18-20, 2023
API CHINA
Nanjing International Expo Center
8 na 9/F, Ụlọ 1, Shenzhen Biopharm Innovating Industrial Park, No. 14, Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen
Oge nzipu: Eprel-19-2023